In force Publication date 25 May 15
Pharmacogenomics of inhaled Beta2-agonists and athletic performance
Resource description
Project Title: Pharmacogenomics of Inhaled Beta2-agonists and athletic performance
Researchers: M. Koehle, J. Rupert, D. McKenzie (University of British Columbia, Canada); B. Sporer (Canadian Sport Centers Pacific)
Year accepted: 2009
Summary: We hypothesize that a subgroup of athletes with certain genetic variations will benefit from 2-agonists while the rest will not. If some athletes are achieving enhanced performance from asthma medication, then the rules surrounding their use in sport will need to be reviewed.